BIXT
Price
$0.14
Change
-$0.00 (-0.00%)
Updated
Jun 6 closing price
Capitalization
12.17M
CYTK
Price
$32.30
Change
+$0.22 (+0.69%)
Updated
Jun 6 closing price
Capitalization
3.83B
52 days until earnings call
Interact to see
Advertisement

BIXT vs CYTK

Header iconBIXT vs CYTK Comparison
Open Charts BIXT vs CYTKBanner chart's image
Bioxytran
Price$0.14
Change-$0.00 (-0.00%)
Volume$96.07K
Capitalization12.17M
Cytokinetics
Price$32.30
Change+$0.22 (+0.69%)
Volume$768.26K
Capitalization3.83B
BIXT vs CYTK Comparison Chart
Loading...
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIXT vs. CYTK commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIXT is a StrongBuy and CYTK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (BIXT: $0.16 vs. CYTK: $30.28)
Brand notoriety: BIXT and CYTK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BIXT: 42% vs. CYTK: 48%
Market capitalization -- BIXT: $12.17M vs. CYTK: $3.83B
BIXT [@Biotechnology] is valued at $12.17M. CYTK’s [@Biotechnology] market capitalization is $3.83B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIXT’s FA Score shows that 0 FA rating(s) are green whileCYTK’s FA Score has 1 green FA rating(s).

  • BIXT’s FA Score: 0 green, 5 red.
  • CYTK’s FA Score: 1 green, 4 red.
According to our system of comparison, both BIXT and CYTK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIXT’s TA Score shows that 6 TA indicator(s) are bullish while CYTK’s TA Score has 5 bullish TA indicator(s).

  • BIXT’s TA Score: 6 bullish, 4 bearish.
  • CYTK’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both BIXT and CYTK are a good buy in the short-term.

Price Growth

BIXT (@Biotechnology) experienced а +13.25% price change this week, while CYTK (@Biotechnology) price change was -3.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

CYTK is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($3.83B) has a higher market cap than BIXT($12.2M). BIXT YTD gains are higher at: 76.863 vs. CYTK (-35.629). BIXT has higher annual earnings (EBITDA): -2.67M vs. CYTK (-493.48M). CYTK has more cash in the bank: 1.08B vs. BIXT (34.7K). BIXT has less debt than CYTK: BIXT (934K) vs CYTK (789M). CYTK has higher revenues than BIXT: CYTK (18.5M) vs BIXT (0).
BIXTCYTKBIXT / CYTK
Capitalization12.2M3.83B0%
EBITDA-2.67M-493.48M1%
Gain YTD76.863-35.629-216%
P/E RatioN/AN/A-
Revenue018.5M-
Total Cash34.7K1.08B0%
Total Debt934K789M0%
FUNDAMENTALS RATINGS
BIXT vs CYTK: Fundamental Ratings
BIXT
CYTK
OUTLOOK RATING
1..100
1753
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
10079
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3792
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIXT's Valuation (85) in the null industry is in the same range as CYTK (100) in the Biotechnology industry. This means that BIXT’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's Profit vs Risk Rating (79) in the Biotechnology industry is in the same range as BIXT (100) in the null industry. This means that CYTK’s stock grew similarly to BIXT’s over the last 12 months.

CYTK's SMR Rating (100) in the Biotechnology industry is in the same range as BIXT (100) in the null industry. This means that CYTK’s stock grew similarly to BIXT’s over the last 12 months.

BIXT's Price Growth Rating (37) in the null industry is somewhat better than the same rating for CYTK (92) in the Biotechnology industry. This means that BIXT’s stock grew somewhat faster than CYTK’s over the last 12 months.

CYTK's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for BIXT (100) in the null industry. This means that CYTK’s stock grew significantly faster than BIXT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIXTCYTK
RSI
ODDS (%)
Bullish Trend 12 days ago
78%
Bullish Trend 12 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
86%
Bullish Trend 12 days ago
80%
Momentum
ODDS (%)
Bullish Trend 12 days ago
82%
Bearish Trend 12 days ago
79%
MACD
ODDS (%)
Bullish Trend 12 days ago
88%
Bullish Trend 12 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
74%
Bearish Trend 12 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
83%
Bearish Trend 12 days ago
78%
Advances
ODDS (%)
Bullish Trend 12 days ago
84%
Bullish Trend about 1 month ago
78%
Declines
ODDS (%)
Bearish Trend 26 days ago
86%
Bearish Trend 12 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
86%
Bullish Trend 12 days ago
83%
Aroon
ODDS (%)
Bearish Trend 12 days ago
79%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

BIXT and

Correlation & Price change

A.I.dvisor tells us that BIXT and CING have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIXT and CING's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIXT
1D Price
Change %
BIXT100%
+1.21%
CING - BIXT
26%
Poorly correlated
+8.99%
CYTK - BIXT
22%
Poorly correlated
-0.82%
APLM - BIXT
21%
Poorly correlated
+1.14%
ANEB - BIXT
20%
Poorly correlated
-4.42%
TTNP - BIXT
20%
Poorly correlated
-0.65%
More

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with IDYA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
-0.82%
IDYA - CYTK
47%
Loosely correlated
+0.72%
KRYS - CYTK
46%
Loosely correlated
-2.44%
ACLX - CYTK
45%
Loosely correlated
-1.29%
IMVT - CYTK
44%
Loosely correlated
-1.33%
TRDA - CYTK
43%
Loosely correlated
+0.91%
More